Joint (NASDAQ:JYNT – Get Free Report) will post its quarterly earnings results after the market closes on Thursday, November 7th. Analysts expect Joint to post earnings of $0.04 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.
Joint (NASDAQ:JYNT – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.05). The company had revenue of $30.26 million during the quarter, compared to the consensus estimate of $29.65 million. Joint had a positive return on equity of 2.17% and a negative net margin of 12.00%. On average, analysts expect Joint to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Joint Stock Up 0.9 %
Shares of JYNT traded up $0.10 during trading hours on Tuesday, reaching $11.20. 2,120 shares of the company traded hands, compared to its average volume of 67,992. Joint has a 12 month low of $7.31 and a 12 month high of $17.82. The company’s fifty day moving average price is $11.22 and its two-hundred day moving average price is $12.99. The company has a market capitalization of $167.97 million, a price-to-earnings ratio of -11.33 and a beta of 1.57.
Joint Company Profile
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
See Also
- Five stocks we like better than Joint
- Investing In Preferred Stock vs. Common Stock
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
- How to Invest in the FAANG Stocks
- NXP Semiconductors Nears Rock Bottom: A Buy Signal Is Expected
- About the Markup Calculator
- NVIDIA, Sherwin-Williams Join the Dow: What Investors Should Know
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.